Published in Hepatology on November 03, 1986
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology (1990) 1.38
Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology (1992) 1.18
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol (1993) 1.05
Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology (1995) 0.83
Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. Transplant Proc (1993) 0.75
Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. Am J Transplant (2015) 2.71
Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63
Liver resections in cirrhotic patients: a Western experience. World J Surg (1986) 2.05
Grasping at molecular interactions and genetic networks in Drosophila melanogaster using FlyNets, an Internet database. Nucleic Acids Res (1999) 2.03
Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A (1991) 1.87
Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg (1998) 1.85
Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol (1992) 1.84
Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg (1999) 1.70
Benefits of combination therapy with flutamide in patients relapsing after castration. Br J Urol (1988) 1.67
Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65
Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A (1993) 1.63
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate. Lancet (1984) 1.49
Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities. J Clin Invest (1986) 1.48
Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst (1999) 1.48
Laparoscopic fenestration of symptomatic non-parasitic cysts of the liver. Br J Surg (1997) 1.46
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol (1993) 1.44
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43
A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J (1999) 1.41
Experimental reduction of portal hypertension by mechanical increase of liver portal flow. Lancet (1991) 1.40
Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology (1995) 1.40
Outcome of laparoscopic transabdominal preperitoneal inguinal hernia repair. Surg Laparosc Endosc (1998) 1.40
A rare laparoscopic diagnosis in acute abdominal pain: torsion of epiploic appendix. Surg Laparosc Endosc (1997) 1.39
Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J Immunol (1988) 1.39
Organ transplant waiting-list in France. Lancet (1997) 1.39
Multiple intrahepatic stones caused by hemobilia in liver transplant recipients. Surgery (1997) 1.39
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma. Eur J Cancer Clin Oncol (1988) 1.38
Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A (1987) 1.36
[Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat]. Therapie (2000) 1.30
Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr (1999) 1.30
Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol (1976) 1.28
A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther (1997) 1.25
Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation. Ann Surg (2001) 1.23
Pulmonary arteriovenous shunting in children with liver disease. J Pediatr (1995) 1.22
Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis. Lancet (1980) 1.21
Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation (1980) 1.16
Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology (1994) 1.14
Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg (1996) 1.12
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications. Ann Oncol (2005) 1.11
Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology (1993) 1.11
Apple II PASCAL programs for molecular biologists. Nucleic Acids Res (1984) 1.11
Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr (1989) 1.10
Fine specificity, idiotypy, and nature of cloned heavy-chain variable region genes of murine monoclonal rheumatoid factor antibodies. Proc Natl Acad Sci U S A (1986) 1.10
Mercuric chloride induced autoimmune disease in Brown-Norway rats: sequential search for anti-basement membrane antibodies and circulating immune complexes. Eur J Clin Invest (1982) 1.06
Criteria for hepatic transplantation in cirrhosis. Surg Gynecol Obstet (1980) 1.06
Postoperative liver insufficiency: prevention and management. World J Surg (1983) 1.06
Surgical management of gallstones in cirrhotic patients. Am J Surg (1983) 1.05
Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol (1996) 1.05
Laparoscopic liver surgery. A report on 28 patients. Surg Endosc (1998) 1.04
Nephrotoxic serum nephritis in the rat: ultrastructural localization of nephrotoxic rabbit antibodies using peroxidase-labeled conjugates. Lab Invest (1972) 1.04
Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology (1992) 1.03
MRI features of a pancreatic schwannoma. Clin Imaging (2005) 1.03
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Aliment Pharmacol Ther (2010) 1.03
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J Steroid Biochem (1985) 1.02
Regulatory arms of the immune network. Immunol Rev (1984) 1.02
Attenuation of liver normothermic ischemia--reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem Pharmacol (2001) 1.02
Extent of hepatectomy in the rat. Evaluation of basal conditions and effect of therapy. Eur Surg Res (1989) 1.00
Experimental toxicity of Peganum harmala seeds. Ann Pharm Fr (2002) 1.00
Microlithiasis of the gallbladder. Surg Gynecol Obstet (1983) 0.99
Utility of operative ultrasound in the surgical management of liver tumors. Ann Surg (1986) 0.99
Intra-abdominal Sengstaken-Blakemore tube placement for acute venous outflow obstruction in reduced-size liver transplantation. Br J Surg (1996) 0.99
Antitumour principles from Peganum harmala seeds. Therapie (2000) 0.98
Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. Exp Cell Res (1994) 0.97
Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes. Chem Biol Interact (1999) 0.97
High frequency of autoantibodies bearing cross-reactive idiotopes among hybridomas using VH7183 genes prepared from normal and autoimmune murine strains. J Clin Invest (1987) 0.95
Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats. Transplant Proc (2008) 0.94
The yemanuclein-alpha: a new Drosophila DNA binding protein specific for the oocyte nucleus. Mech Dev (1992) 0.94
Gastrointestinal mucormycosis and liver transplantation; a case report and review of the literature. Transpl Int (1999) 0.94
Possibilities of laparoscopic liver resection. J Hepatobiliary Pancreat Surg (2000) 0.94
Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction. Cell Death Differ (2001) 0.93
Distribution of heterologous antiperoxidase antibodies and their fragments in the superficial renal cortex of normal Wistar-Munich rat: an ultrastructural study. Lab Invest (1978) 0.93
[Operative risk in hepatectomies. Experience with 154 hepatectomies]. Chirurgie (1983) 0.92
Emergency liver retransplantation using a polycystic donor liver. Transplantation (1994) 0.92
Metastatic endocrine tumors: is there a place for liver transplantation? Liver Transpl Surg (1995) 0.92
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci (2003) 0.92
Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol (1996) 0.92
Immunochemical and molecular characterization of regulatory idiotopes expressed by monoclonal antibodies exhibiting or lacking beta 2-6 fructosan binding activity. J Exp Med (1985) 0.92
Biliary complications after transplantation in children: role of imaging modalities. Pediatr Radiol (1991) 0.92
Liver apoptosis following normothermic ischemia-reperfusion: in vivo evaluation of caspase activity by FLIVO assay in rats. Transplant Proc (2008) 0.91
Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology (1994) 0.91
Liver transplants from living related donors. Annu Rev Med (2001) 0.91
Liver transplantation in children with Alagille syndrome--a study of twelve cases. Transplantation (1995) 0.91
Orthotopic liver transplantation for Byler disease. Transplantation (1990) 0.90
Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. Hepatology (1997) 0.90
Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone. Cell Death Differ (2002) 0.90
Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg (1989) 0.90
V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig). Immunol Rev (1994) 0.90
[Diuretic activity of the infusion of flowers from Lavandula officinalis]. Reprod Nutr Dev (2002) 0.89
Protein-losing enteropathy secondary to hepatic venous outflow obstruction after liver transplantation. J Hepatol (1997) 0.89
Risk and prognostic factors of gut perforation after orthotopic liver transplantation for biliary atresia. Liver Transpl Surg (1995) 0.88
Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int Immunol (1993) 0.88
Use of antidiabetic plants in Morocco and Québec. Diabetes Care (2001) 0.88
JNK(1)/SAPK(1) involvement in hypoxia-reoxygenation-induced apoptosis in rat hepatocytes. Transplant Proc (2001) 0.88
Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation (1993) 0.88
Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial function. J Pharmacol Exp Ther (1998) 0.88
Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg (1995) 0.88